New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ABVC BioPharma, Inc.
ABVC
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

6M

Biotechnology

Next Earning date - 12 Mar 2025

6M

Biotechnology

Next Earning date - 12 Mar 2025

0.46USD

Shape0.04 ( 8.95%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

16%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

74%

Quote Panel

Shape
Updated February 17, 2025
1W 8.43 % 1M -15.65 % 3M -10.56 % 1Y -61.96 %

Key Metrics

Shape
  • Market Cap

    5.92M


  • Shares Outstanding

    12.98M


  • Share in Float

    11.13M


  • Dividende

    0


  • Earning Date

    12 Mar 2025


  • Price Target

    0.4565


  • Average Volume

    205528


  • Beta

    0.672


  • Range

    0.4-1.73


  • Industry

    Biotechnology


  • Website

    https://www.abvcpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

ABVC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4M

Shape972%

2025-Revenue

$4.60

Shape-30567%

2025-EPS

$4M

Shape-4605%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Maxim Group

downgrade

Previous: Not converted

2022-11-16

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.60
vs -0.81

Q3.22

arrow
arrow

N/A

-1.10
vs -0.70

Q4.22

arrow
arrow

N/A

-1.50
vs -0.31

Q1.23

arrow
arrow

N/A

-0.60
vs -2.00

Q2.23

arrow
arrow

N/A

-0.68
vs -0.60

Q3.23

arrow
arrow

N/A

-0.82
vs -1.10

Q4.23

arrow
arrow

N/A

-0.35
vs -1.50

Q1.24

arrow
arrow

N/A

-0.40
vs -0.60

Q2.24

arrow
arrow

N/A

-0.09
vs -0.68

Q3.24

arrow
arrow

N/A

-0.02
vs -0.82

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+895%

312.9K  vs 31.4K

Q3.22

arrow
arrow

-57%

42.3K  vs 99K

Q4.22

arrow
arrow

+1658%

589K  vs -37793

Q1.23

arrow
arrow

+400%

128.3K  vs 25.7K

Q2.23

arrow
arrow

-98%

6.1K  vs 312.9K

Q3.23

arrow
arrow

-62%

15.9K  vs 42.3K

Q4.23

arrow
arrow

-100%

2.2K  vs 589K

Q1.24

arrow
arrow

-99%

1.2K  vs 128.3K

Q2.24

arrow
arrow

+1818%

117.1K  vs 6.1K

Q3.24

arrow
arrow

+2351%

389.3K  vs 15.9K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-145%

-1.45
vs -0.64

Q1.23

arrow
arrow

-4%

-0.04
vs -1.45

Q2.23

arrow
arrow

+597%

5.97
vs -0.04

Q3.23

arrow
arrow

-36%

-0.36
vs 5.97

Q4.23

arrow
arrow

-35%

-0.35
vs -0.36

Q1.24

arrow
arrow

-49%

-0.49
vs -0.35

Q2.24

arrow
arrow

-12%

-0.12
vs -0.49

Q3.24

arrow
arrow

-2%

-0.02
vs -0.12

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

9

9
vs NA

NA

Q4.21

arrow
arrow

5

5
vs 9

-44%

Q1.22

arrow
arrow

4

4
vs 5

-20%

Q2.22

arrow
arrow

5

5
vs 4

25%

Q3.22

arrow
arrow

9

9
vs 5

80%

Q4.22

arrow
arrow

9

9
vs 9

NA

Q1.23

arrow
arrow

9

9
vs 9

NA

Q2.23

arrow
arrow

8

8
vs 9

-11%

Earnings Growth

Latest News